JP2024529899A5 - - Google Patents
Info
- Publication number
- JP2024529899A5 JP2024529899A5 JP2024502462A JP2024502462A JP2024529899A5 JP 2024529899 A5 JP2024529899 A5 JP 2024529899A5 JP 2024502462 A JP2024502462 A JP 2024502462A JP 2024502462 A JP2024502462 A JP 2024502462A JP 2024529899 A5 JP2024529899 A5 JP 2024529899A5
- Authority
- JP
- Japan
- Prior art keywords
- glycero
- rna
- guide
- guide rna
- phosphocholine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (9)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| USPCT/US2021/042100 | 2021-07-16 | ||
| PCT/US2021/042100 WO2022016121A2 (en) | 2020-07-16 | 2021-07-16 | Gene editing to improve joint function |
| US202163222972P | 2021-07-17 | 2021-07-17 | |
| US63/222,972 | 2021-07-17 | ||
| US202263300822P | 2022-01-19 | 2022-01-19 | |
| US63/300,822 | 2022-01-19 | ||
| US202263326571P | 2022-04-01 | 2022-04-01 | |
| US63/326,571 | 2022-04-01 | ||
| PCT/US2022/037490 WO2023288135A2 (en) | 2021-07-16 | 2022-07-18 | Gene editing to improve joint function |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024529899A JP2024529899A (ja) | 2024-08-14 |
| JP2024529899A5 true JP2024529899A5 (enExample) | 2025-07-24 |
Family
ID=84919676
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024502462A Pending JP2024529899A (ja) | 2021-07-16 | 2022-07-18 | 関節機能を改善する遺伝子編集 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20230235321A1 (enExample) |
| EP (1) | EP4370165A4 (enExample) |
| JP (1) | JP2024529899A (enExample) |
| KR (1) | KR20240095529A (enExample) |
| CN (1) | CN119110732A (enExample) |
| AU (1) | AU2022311936A1 (enExample) |
| CA (1) | CA3226089A1 (enExample) |
| IL (1) | IL310118A (enExample) |
| MX (1) | MX2024000821A (enExample) |
| WO (1) | WO2023288135A2 (enExample) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2024215959A2 (en) * | 2023-04-11 | 2024-10-17 | Orthobio Therapeutics, Inc. | Lipid nanoparticles for gene editing systems |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20050282198A1 (en) * | 1997-05-29 | 2005-12-22 | Interleukin Genetics, Inc. | Diagnostics and therapeutics for diseases associated with an IL-1 inflammatory haplotype |
| EP3230452B1 (en) * | 2014-12-12 | 2025-06-11 | The Broad Institute, Inc. | Dead guides for crispr transcription factors |
| EP3374494A4 (en) * | 2015-11-11 | 2019-05-01 | Coda Biotherapeutics, Inc. | CRISPR COMPOSITIONS AND METHODS OF USE THEREOF FOR GENE THERAPY |
| ES3030658T3 (en) * | 2016-03-30 | 2025-07-01 | Intellia Therapeutics Inc | Lipid nanoparticle formulations for crispr/cas components |
| US11807850B2 (en) * | 2017-12-06 | 2023-11-07 | Klogenix Llc | Compositions and methods for modulating gene expression |
| CN112533942A (zh) * | 2018-06-01 | 2021-03-19 | 华盛顿大学 | 嵌合抗原受体细胞疗法中细胞因子释放综合征的抑制 |
| CA3121191A1 (en) * | 2018-11-28 | 2020-06-04 | Crispr Therapeutics Ag | Optimized mrna encoding cas9 for use in lnps |
| WO2020150633A1 (en) * | 2019-01-18 | 2020-07-23 | Orthobio Therapeutics, Inc. | Gene editing to improve joint function |
| CA3144356A1 (en) * | 2019-06-21 | 2020-12-24 | Function Oncology, Inc. | A genetic pharmacopeia for comprehensive functional profiling of human cancers |
-
2022
- 2022-07-18 IL IL310118A patent/IL310118A/en unknown
- 2022-07-18 WO PCT/US2022/037490 patent/WO2023288135A2/en not_active Ceased
- 2022-07-18 EP EP22842979.1A patent/EP4370165A4/en active Pending
- 2022-07-18 MX MX2024000821A patent/MX2024000821A/es unknown
- 2022-07-18 KR KR1020247005395A patent/KR20240095529A/ko active Pending
- 2022-07-18 CN CN202280062090.XA patent/CN119110732A/zh active Pending
- 2022-07-18 JP JP2024502462A patent/JP2024529899A/ja active Pending
- 2022-07-18 CA CA3226089A patent/CA3226089A1/en active Pending
- 2022-07-18 AU AU2022311936A patent/AU2022311936A1/en active Pending
- 2022-07-18 US US17/867,486 patent/US20230235321A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20240374512A1 (en) | Compositions and methods for targeted delivery to cells | |
| JP7822173B2 (ja) | アルギニノコハク酸合成酵素欠損症のｍＲＮＡ治療 | |
| AU2021201357B2 (en) | Stereochemically enriched compositions for delivery of nucleic acids | |
| JP7308000B2 (ja) | Ｖｅｇｆ－ａポリペプチドをコードする改変ｒｎａを送達するための脂質ナノ粒子 | |
| JP2023538260A (ja) | ペイロード分子を気道上皮に送達するための組成物 | |
| US12351834B2 (en) | Compositions and methods for the treatment of ornithine transcarbamylase deficiency | |
| EP3641834B1 (en) | Messenger rna therapy for the treatment of friedreich's ataxia | |
| WO2021222801A2 (en) | Nucleic acids and methods of treatment for cystic fibrosis | |
| JP7789103B2 (ja) | 原発性線毛機能不全症の治療のための組成物および方法 | |
| JP2022502451A5 (enExample) | ||
| CN117177738A (zh) | 通过混合的阳离子性脂质颗粒的组织特异性核酸递送 | |
| WO2023081776A1 (en) | Lipid formulations containing nucleic acids and methods of treatment for cystic fibrosis | |
| US20240216515A1 (en) | Compositions and methods for targeted delivery to cells | |
| JP2014534232A (ja) | 脂質−核酸粒子を無菌的に生成するための単回使用システム | |
| JP2024545584A (ja) | ペイロード分子を気道上皮に送達するための組成物 | |
| EP4456921A2 (en) | Compositions and methods for targeted delivery to cells | |
| EP4087619A1 (en) | Formulations for delivery of oligonucleotides to lung cells | |
| US20240197641A1 (en) | Compositions and methods for targeted systemic delivery to cells | |
| CN102727436A (zh) | 核酸脂质体药物制剂 | |
| WO2024216128A1 (en) | Trems for use in correction of missense mutations | |
| JP2026514001A (ja) | Ｔｒｅｍ組成物及びその使用方法 | |
| CN120022384A (zh) | 脂质纳米颗粒在肿瘤治疗中的用途 | |
| WO2026102108A1 (en) | Dna production methods | |
| JP2024545572A (ja) | 原発性線毛機能不全の治療のための組成物及び方法 |